• Cost Analysis of Management of Cardiovascular Disease Comorbidities in Turkey
• Analysis of Gene and Cell Therapies Policies in European Countries
• Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Turkey
• Analysis of Psychotropic Medications Prescriptions in Turkey
• Incidence of Unlicensed and Off-Label Prescription in the Treatment of Urological Cancers in Turkey: Assessment of Legislative and Regulatory Policy

• PGI25 Clinic and Economic Analysis for Diagnisis and Treatment of Difficult Bile Duct Stones with Singel Operator Cholangiiscopy in Turkey
• PCV48 Cost Effectiveness of Rivaroxaban in Coronary Artery Disease and/or Peripheral Artery Disease for 5 Differen Patient SUB-GROUPS in Turkey
• PMS32 Cost Minimization Analysis of Zentius for the Treatment of Vitamin D and Calcium Deficiency in Turkey
• PCN301 Patient Access to Personalized Oncology Medicines in TURKEY
• PNS188 Analysis of Market Access Agreements in Turkey
• PCV75 Cost Analysis of Complications with Coronary Artery Disease or Peripheral Artery Disease in Turkey
• PND32 Cost-Efectiveness and Budget Impact of Vagus Nerve Stimulation with Aspire sr Model 106 Compared to Anti-Epileptic Drugs in a Subgroup of Patients with Drug Resistant Epilepsy in Public Setting in Turkey
• PSY33 HTA Review of Decisions for Products Indicated in the Treatment of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (N) in UK, Germany, France, Italy, Spain, Canada and Turkey
• PNS159 Pharmacoeconomics and Health Outcome Studies in Turkey: ISPOR Database Search
• PBI42 Analysis of Gene and Cell Therapies Policies in European Countrie
• PCV61 Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Turkey
• PCV94 Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Lithuania
• PRO75 Patient Access to Orphan Medicines in Turkey

• Menorajide Güncel Yaklaşımlar Çalıştayı
• Nadir Hastalıklar Hasta ve Hasta Yakınları İhtiyaç Analizi Ortak Akıl Platformu
• Türkiye Pazar Erişim, Ruhsat ve Medikal Alan Anketi
• HTA Decisions Reviewfor Products Indicated in the Treatment of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis in EU5 countries, Canada and Turkey

• Sosyoekonomik Durumun Diyabet ile İlişkisi ve Diyabete Etkisinin İncelenmesi
• COVID-19 Tanı Yöntemleri̇ne Bakış: Hızlı Si̇stemati̇k İnceleme
• Health Policies About Gene & Cell Therapies in France, Germany, Italy, United Kingdom, Spain, Portugal and Turkey
• A Market Research Of Obesity And Bariatric Surgery In Turkey And Tunisia
• Efficacy and Safety of PD-1/PD-l1 inhibitors Used in the Treatment of Patients with Advanced and Metastatic Melanoma-A Systematic Review and Network Meta-Analysis

• PIN54 Economic IMPACT of Use of Preventive 1000 MG/Day Vitamin C in FLU Season Depending on a Decision Tree MODEL for Turkey
• PIN27 Economic IMPACT of Use of Preventive 1000 MG/Day Vitamin C in FLU Season Depending on Markov a MODEL for Turkey
• PIN53 Cost of Productivity Loss of Common Cold and FLU in Turkey
• PCN198 Access Status of Oncology Medicines Depending on Genetic Profiling in Turkey
• PSS6 Loss of Productivity Due to Visual Impairment in Turkey
• PRO49 Cost-Consequences Analysis of Current and Upcoming Hemophilia-a Treatments in Turkey
• PNS97 The TREND of Health Economics and Outcome Studies from Turkey Published in Ispor
• PNS83 Analysis of Market Access Agreements in Turkey
• PMH28 Antidepressant Consumption in Turkey between 2015-2017: Panel DATA Analysis
• PIN56 Cost of COVID-19 Patients Treatment in Turkey
• PIN8 A MODEL for Estimation of Possible COVID-19 Patient Numbers in Turkey
• PMU15 Comparison of Clinical and Economical Outcomes of Alternative Imaging Methods in Turkey
• PCV26 COMPARISON OF CLINICAL AND ECONOMIC OUTCOMES OF MAGNETIC RESONANCE IMAGING WITH GADOBUTROL, GADOTERIC ACID AND PERIPHERAL ANGIOGRAPHY IN DIAGNOSIS OF VASCULAR DISEASES
• PDB55 Analysis of Obesity and Bariatric Surgery for Turkey
• PCN155 Comparison of Clinical and Economic Outcomes of Gadoxetic-Acid and Extracellular Contrast Agent Magnetic Resonance Imaging and Contrast Computed Tomography in the Diagnosis of Liver Metastasis

• COVID-19 Salgını Sağlık Sektörü Etki Anketi Temmuz 2020
• Dünya ve Türkiye COVID-19 Analizi
• Dünya ve Türkiye COVID-19 Kaynaklı Vaka Sayıları ve Muhtemel Senaryolar Analizi (5 Mayıs)
• Dünya ve Türkiye COVID-19 Kaynaklı Vaka Sayıları ve Muhtemel Senaryolar Analizi (15 Nisan)
• Dünya ve Türkiye COVID-19 Kaynaklı Vaka Sayıları ve Muhtemel Senaryolar Analizi (6 Nisan)
• Türkiye COVID-19 Kaynaklı Muhtemel Vaka Sayıları ve Sağlık Hizmeti İhtiyaç Analizi (24 Mart)
• 2020 Yılı İlaçta Sabit Euro Kuru Beklenti Anketi
• Kamu Geri Ödeme İlaç Tedbirleri Beklenti Anketi

• Cost Effectiveness Analysis of the Triclip™ Transcatheter Tricuspid Valve Repair System in Patients with Tricuspid Regurgitation (Yayın aşamasında)
• Analysis of Patient Access to Orphan Drugs in Turkey
• Determining the Impact of Vitamin C Use with the Common Cold on Loss of Labour and Medical Treatment Costs for Turkey
• Changes in Catastrophic Health Expenditures Depending on Health Policies in Turkey
• Accelerated Globalization and Its Impact to the World’s Health Care Achievement

• Nadir Hastalıklarla Yaşayan Hanelerin Cepten Yaptıkları Sağlık Harcamaları
• Amerika Birleşik Devletleri Yeni Dönem Beklenen İlaç Politikaları ve Türkiye’ye Muhtemel Yansımaları
• Besin Takviyeleri Fiyat Değişim Değerlendirmesi
• Sosyal Güvenlik Kurumu Geri Ödeme Eşdeğer Bant Değişikliği Fiyat Farkı Etkisi Analizi
• COVID-19’un Türkiye Kamu ve Özel Sağlık Sigorta Harcamalarına Etkisi
• 2020 Yılı Detaylı İlaç Listesi Analizi
• COVID-19 Pandemisi İlk Yıl Değerlendirmesi
• ECONiX Araştırma 2021 Yılı İlaç Dönemsel Avro Kuru ve Şirket Kuru Beklenti Anketi

• Antidepressant use in Turkey by provinces: panel data analysis.
• Cost-Effectiveness Analysis of the Triclip™ Transcatheter Tricuspid Valve Repair System in Patients with Tricuspid Regurgitation.
• TÜRKİYE’DE KOLOREKTAL KANSER TARAMALARININ MALİYET ETKİLİLİK ANALİZİ.
• Gene and Cell Therapies Overview Under The Light of Health Economics.

ECONiX 2022 Yılı İlaç Dönemsel Sabit Avro Kuru Beklenti Anketi
2021 Yılı Türkiye’de İlaçların Uluslararası Referans Fiyatlandırma Analizi
2021 Yılı Türkiye’de Kamu Sağlık Sigortası Harcamalarının Değerlendirilmesi
2010 – 2021 Yılları Arası Türkiye İlaç Geri Çekme Analizi
GERÇEK YAŞAM VERİLERİ İLE TÜRKİYE DÜŞÜK EJEKSİYON FRAKSİYONLU KALP YETERSİZLİĞİ HASTALIK MALİYETİ
HEART FAILURE WITH REDUCED EJECTION FRACTION COST IN TURKEY WITH REAL WORLD DATA
POSSIBLE IMPACT OF BIDEN ADMINISTRATION`S PHARMACEUTICAL POLICIES ON TURKEY
Türkiye Yüksek Öğretim Kurumu Verileri İle Tıp Fakülteleri İnceleme Raporu
2007-2021 Yılları Arasında Türkiye İlaç Pazarında Yaşanan Değişimlerin İncelenmesi
HIV / AIDS Dünya ve Türkiye Değerlendirmesi
SAĞLIK SEKTÖRÜNDE ÜRETİM MALİYETLERİNİ ETKİLEYEN MAL VE HİZMET FİYATLARINDA YAŞANAN DEĞİŞİMLERİN İNCELENMESİ